Increasing warfarin dosage reductions associated with concurrent warfarin and repeated cycles of 5-fluorouracil therapy

Pharmacotherapy

Volumn 25, Issue 3, 2005, Pages 442-447

  Davis, David A ^a   Fugate, Susan E ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

5 fluorouracil; Anticoagulation; Chemotherapy; Drug interaction; Warfarin

Indexed keywords

CHOLINE MAGNESIUM TRISALICYLATE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; LOPERAMIDE; METHOTREXATE; PROCHLORPERAZINE; VINBLASTINE; VITAMIN K GROUP; WARFARIN;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CASE REPORT; COLON ADENOCARCINOMA; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG EFFECT; EPISTAXIS; FEMALE; HEMATOCHEZIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; NAUSEA; VOMITING;

ADENOCARCINOMA; ANTICOAGULANTS; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; DRUG SYNERGISM; FEMALE; FLUOROURACIL; HUMANS; INTERNATIONAL NORMALIZED RATIO; MIDDLE AGED; WARFARIN;

EID: 14544308295     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.3.442.61598     Document Type: Article

References (26)

1. Kwaan HC, Parmar S, Wang J. Pathogenesis of increased risk of thrombosis in cancer. Semin Thromb Hemost 2003;29: 283-90.
2. Aki Z, Kotiloglu G, Ozyilkan O. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin [letter]. Am J Gastroenterol 2000;95:1093-4.
3. Brown MC. Multisite mucous membrane bleeding due to a possible interaction between warfarin and 5-fluorouracil. Pharmacotherapy 1997;17:631-3.
4. Brown MC. An adverse reaction between warfarin and 5-fluorouracil: a case report and review of the literature. Chemotherapy 1999;45:392-5.
5. Carabino J, Wang F. International normalized ratio fluctuation with warfarin-fluorouracil therapy [letter]. Am J Health-Syst Pharm 2002;59:875.
6. Kolesar JM, Johnson CL, Freeberg BL, Berlin JD, Schiller JH. Warfarin-5-FU interaction: a consecutive case series. Pharmacotherapy 1999;19:1445-9.
7. Malacarne P, Maestri A. Possible interactions between antiblastic agents and warfarin inducing prothrombin time abnormalities [letter]. Recent Prog Med 1996;83:135.
8. Scarfe MA, Israel MK. Possible interaction between warfarin and combination of levamisole and fluorouracil. Ann Pharmacother 1994;28:464-7.
9. Wajima T, Makhopadhyay P. Possible interactions between warfarin and 5-fluorouracil [letter]. Am J Hematol 1992;40:238.
10. Wehbe TW, Warth JA. A case of bleeding requiring hospitalization that was likely caused by an interaction between warfarin and levamisole. Clin Pharmacol Ther 1996;59:360-2.
11. Lee CR, Goldstein JA, Pieper JA. Cytochrome P450 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics 2002;12:251-63.
12. Kaminsky LS, Zhang ZY. Human P450 metabolism of warfarin. Pharmacol Ther 1997;73:67-74.
13. Zhou Q, Chan E. Effect of 5-fluorouracil on the anticoagulant activity and the pharmacokinetics of warfarin enantiomers in rats. Eur J Pharm Sci 2002;17:73-80.
14. Sicor Pharmaceuticals, Inc. Adrucil (fluorouracil injection, USP) package insert. Irvine, CA; 2003.
15. O'Reilly RA. The stereoselective interaction of warfarin and metronidazole in man. N Engl J Med. 1976;295:354-7.
16. Kazmier FJ. A significant interaction between metronidazole and warfarin. Mayo Clin Proc 1976;51:782-4.
17. Dean RP, Talbert RL. Bleeding associated with concurrent warfarin and metronidazole therapy. Drug Intell Clin Pharm 1980;14:864-6.
18. Byrd DC, Gaskins SE, Parrish AM, Freeman LB. Warfarin and ciprofloxacin interaction: case report and controversy. J Am Board Fam Pract 1999;12:486-8.
19. Bianco TM, Bussey HI, Farnett LE, Linn WD, Roush MK, Wong YWJ. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation. Pharmacotherapy 1992;12:435-9.
20. Renzi R, Finkbeiner S. Ciprofloxacin interaction with sodium warfarin: a potentially dangerous side effect. Am J Emerg Med 1991;9:551-2.
21. Mott FE, Murphy S, Hunt V. Ciprofloxacin and warfarin [letter]. Ann Intern Med 1989;111:542.
22. Linville D, Emory C, Graves L. Ciprofloxacin and warfarin interaction [letter]. Am J Med 1991;90:765.
23. Smith JK, Aljazairi A, Fuller SH. INR elevation associated with diarrhea in a patient receiving warfarin. Ann Pharmacother 1999;33:301-4.
24. Black JA. Diarrhoea, vitamin K, and warfarin [letter]. Lancet 1994;344:1373.
25. Lubetsky A, Dekel-Stern E, Chetrit A, Lubin F, Halkin H. Vitamin K intake and sensitivity to warfarin in patients consuming regular diets. Thromb Haemost 1999;81:396-9.
26. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.